Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients.
Two patients with primary hepatic malignancy were treated by hepatectomy and orthotopic liver transplantation. In both cases the donor liver was infused with cold solutions and kept chilled without continuous perfusion. There was immediate satisfactory hepatic function in both transplants.The first patient died after 11 weeks from overwhelming bacterial and fungal infections probably secondary to hepatic infarction due to thrombosis of the recipient hepatic artery. The thrombus occurred at the site of the arterial clamp. In an attempt to control the growth before transplantation, the patient had been treated with large doses of chlorambucil, which resulted in extreme marrow depression and septicaemia.The second patient developed cholestatic jaundice during the second and third weeks after transplantation, with histological evidence of mild rejection, which was controlled by increasing the dose of immunosuppressive agents. He is now well, having returned to work six weeks after the operation.Though the first patient showed no evidence of rejection, it is concluded that patients receiving liver allografts should receive immunosuppressive therapy.
D000328:Adult; D001780:Blood Coagulation Tests; D002699:Chlorambucil / Q000009:adverse effects; D005260:Female; D006498:Hepatectomy; D006499:Hepatic Artery; D006506:Hepatitis A / Q000209:etiology; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007565:Jaundice / Q000150:complications; D008113:Liver Neoplasms / Q000188:drug therapy / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D013927:Thrombosis / Q000150:complications; D014021:Tissue Preservation; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D002699:Chlorambucil